文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

COVID-19 中的免疫反应:下一步是什么?

Immune response in COVID-19: what is next?

机构信息

The Third Affiliated Hospital of Soochow University/The First People's Hospital of Changzhou, State Key Laboratory of Radiation Medicine and Protection, Institutes for Translational Medicine of Soochow University, Medical College, Suzhou, China.

CAS Key Laboratory of Tissue Microenvironment and Tumor, Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences/Shanghai Jiao Tong University School of Medicine, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China.

出版信息

Cell Death Differ. 2022 Jun;29(6):1107-1122. doi: 10.1038/s41418-022-01015-x. Epub 2022 May 17.


DOI:10.1038/s41418-022-01015-x
PMID:35581387
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9110941/
Abstract

The coronavirus disease 2019 (COVID-19) has been a global pandemic for more than 2 years and it still impacts our daily lifestyle and quality in unprecedented ways. A better understanding of immunity and its regulation in response to SARS-CoV-2 infection is urgently needed. Based on the current literature, we review here the various virus mutations and the evolving disease manifestations along with the alterations of immune responses with specific focuses on the innate immune response, neutrophil extracellular traps, humoral immunity, and cellular immunity. Different types of vaccines were compared and analyzed based on their unique properties to elicit specific immunity. Various therapeutic strategies such as antibody, anti-viral medications and inflammation control were discussed. We predict that with the available and continuously emerging new technologies, more powerful vaccines and administration schedules, more effective medications and better public health measures, the COVID-19 pandemic will be under control in the near future.

摘要

新型冠状病毒病 (COVID-19) 已在全球大流行超过 2 年,它以前所未有的方式持续影响着我们的日常生活方式和质量。我们迫切需要更好地了解针对 SARS-CoV-2 感染的免疫及其调节。基于目前的文献,我们在这里回顾了各种病毒突变以及疾病表现的不断演变,同时特别关注固有免疫反应、中性粒细胞胞外陷阱、体液免疫和细胞免疫的变化。根据其引发特定免疫的独特特性,对不同类型的疫苗进行了比较和分析。讨论了各种治疗策略,如抗体、抗病毒药物和炎症控制。我们预测,随着现有和不断涌现的新技术、更强大的疫苗和接种计划、更有效的药物和更好的公共卫生措施,COVID-19 大流行将在不久的将来得到控制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/271e/9177750/795376d536e2/41418_2022_1015_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/271e/9177750/37a6692356e3/41418_2022_1015_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/271e/9177750/8e465c7ff31a/41418_2022_1015_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/271e/9177750/3bd25515f47d/41418_2022_1015_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/271e/9177750/d7d10c4576e2/41418_2022_1015_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/271e/9177750/70c895ab37a9/41418_2022_1015_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/271e/9177750/795376d536e2/41418_2022_1015_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/271e/9177750/37a6692356e3/41418_2022_1015_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/271e/9177750/8e465c7ff31a/41418_2022_1015_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/271e/9177750/3bd25515f47d/41418_2022_1015_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/271e/9177750/d7d10c4576e2/41418_2022_1015_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/271e/9177750/70c895ab37a9/41418_2022_1015_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/271e/9177750/795376d536e2/41418_2022_1015_Fig6_HTML.jpg

相似文献

[1]
Immune response in COVID-19: what is next?

Cell Death Differ. 2022-6

[2]
Could "trained immunity" be induced by live attenuated vaccines protect against COVID-19? Review of available evidence.

J Infect Dev Ctries. 2020-9-30

[3]
Fighting the SARS-CoV-2 pandemic requires a global approach to understanding the heterogeneity of vaccine responses.

Nat Immunol. 2022-3

[4]
SARS-CoV-2 will constantly sweep its tracks: a vaccine containing CpG motifs in 'lasso' for the multi-faced virus.

Inflamm Res. 2020-7-12

[5]
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.

J Biol Regul Homeost Agents. 2021

[6]
Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.

Cells. 2021-10-29

[7]
Immunity in SARS-CoV-2 Infection: Clarity or Mystery? A Broader Perspective in the Third Year of a Worldwide Pandemic.

Arch Immunol Ther Exp (Warsz). 2023-2-21

[8]
Induction of High Levels of Specific Humoral and Cellular Responses to SARS-CoV-2 After the Administration of Covid-19 mRNA Vaccines Requires Several Days.

Front Immunol. 2021

[9]
[Investigation of SARS-CoV-2-Specific Humoral and Cellular Immunity Values in Health Care Workers with COVID-19 Disease and Administered with COVID-19 Vaccine].

Mikrobiyol Bul. 2022-7

[10]
Low SARS-CoV-2 infection rates and high vaccine-induced immunity among German healthcare workers at the end of the third wave of the COVID-19 pandemic.

Int J Hyg Environ Health. 2021-9

引用本文的文献

[1]
Previous COVID-19 infection significantly reduces elastase levels in newly diagnosed pulmonary tuberculosis patients.

Front Immunol. 2025-7-31

[2]
Mesenchymal stromal cell secretome reduces lung injury and thrombo-inflammation induced by SARS-CoV-2 spike protein.

Stem Cell Res Ther. 2025-7-1

[3]
Survival and prognostic factors in rhino-orbito-cerebral mucormycosis: A 3-year cohort study.

Sci Rep. 2025-5-8

[4]
Robust COVID-19 Vaccine Responses Despite Filarial Co-Infection: Insights from a Lymphatic Filariasis Cohort in Ghana.

Vaccines (Basel). 2025-3-13

[5]
Helminth Seropositivity Inversely Correlated with Th1 and Th17 Cytokines and Severe COVID-19.

Vaccines (Basel). 2025-2-27

[6]
Anti-nucleocapsid and anti-spike antibody trajectories in people with post-covid condition versus acute-only infections: a nested longitudinal case-control study within the Virus Watch prospective cohort.

Nat Commun. 2025-4-17

[7]
Impact of Maternal Exposure to SARS-CoV-2 on Immunological Components of Breast Milk.

Int J Mol Sci. 2025-3-13

[8]
Identification of biomarkers in Alzheimer's disease and COVID-19 by bioinformatics combining single-cell data analysis and machine learning algorithms.

PLoS One. 2025-2-18

[9]
Single-cell transcriptome-wide Mendelian randomization and colocalization reveals immune-mediated regulatory mechanisms and drug targets for COVID-19.

EBioMedicine. 2025-3

[10]
Different immunological characteristics of asymptomatic and symptomatic COVID-19 patients without vaccination in the acute and convalescence stages.

PeerJ. 2025-1-29

本文引用的文献

[1]
Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant.

Nat Commun. 2022-5-13

[2]
The Interplay Between Coronavirus and Type I IFN Response.

Front Microbiol. 2022-3-4

[3]
Antibody evasion properties of SARS-CoV-2 Omicron sublineages.

Nature. 2022-4

[4]
Different pathogenesis of SARS-CoV-2 Omicron variant in wild-type laboratory mice and hamsters.

Signal Transduct Target Ther. 2022-2-25

[5]
Fighting the SARS-CoV-2 pandemic requires a global approach to understanding the heterogeneity of vaccine responses.

Nat Immunol. 2022-3

[6]
Evolution of resistance to COVID-19 vaccination with dynamic social distancing.

Nat Hum Behav. 2022-2

[7]
Co-circulation of two SARS-CoV-2 variant strains within imported pet hamsters in Hong Kong.

Emerg Microbes Infect. 2022-12

[8]
Scientists deliberately gave people COVID - here's what they learnt.

Nature. 2022-2

[9]
Recognition and inhibition of SARS-CoV-2 by humoral innate immunity pattern recognition molecules.

Nat Immunol. 2022-2

[10]
Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2.

Cell. 2022-2-17

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索